Skip to main content

Advertisement

SpringerLink
Log in

Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

Human African trypanosomiasis (HAT), otherwise known as sleeping sickness, has remained a disease with no effective treatment. Recent progress in HAT research suggests that a vaccine against the disease is far from being successful. Also the emergence of drug-resistant trypanosomes makes further work in this area imperative. So far the treatment for the early stage of HAT involves the drugs pentamidine and suramin which have been very successful. In the second stage of the disease, during which the trypanosomes reside in the cerebrospinal fluid (CSF), treatment is dependent exclusively on the arsenical compound melarsoprol. This is largely due to the inability to find compounds that can cross the blood brain barrier and kill the CSF-residing trypanosomes. This review summarises our current understanding on the treatment of HAT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  • Barret MP (2000) Problems for the chemotherapy of human African trypanosomiasis. Curr Opin Infect Dis 13:647–651

    PubMed  Google Scholar 

  • Barret MP, Fairlamb AH (1999) The biochemical basis of arsenical-diamidine cross resistance in African trypanosomes. Parasitol Today 15:136–140

    Article  CAS  PubMed  Google Scholar 

  • Basselin M, Lawrence F,Robert-Gero M (1997) Polyamine and pentamidine metabolism in African trypanosomes. Acta Trop 54: 215–224

    Google Scholar 

  • Basselin M, Coombs GH, Barret MP (2000) Putrecine and spermidine transport in Leishmania. Mol.Biochem Parasitol 109:37–46

    Article  CAS  Google Scholar 

  • Berger BJ, Carter NS, Fairlamb AH (1993) Characterization of Pentamidine-resistant.T.b.brucei. Mol Biochem Parasitol 69:289

    Article  Google Scholar 

  • Berger BJ, Carter NS, Fairlamb AH (1995) Characterization of Pentamidine-resistant T. b. brucei. Mol Biochem Parasitol 69:289–298

    Article  CAS  PubMed  Google Scholar 

  • Bitonti AJ, Dumont JA, McCann PP (1986). Characterization of T. b. brucei S-adenosyl methionine decarboxylase and its inhibition by berenil, pentamidine, methylglyoxal (bis guynylhydrazone). Biochem J 237:685–689

    CAS  PubMed  Google Scholar 

  • Bronner U, Douoa F, Ericsson O, Gustafsson LL, Miezan TW, Rais M (1991) Pentamidine concentrations in plasma, whole blood, and cerebrospinal fluid during treatment of T. b. gambiense infection in Cote d'Ivoire. Trans R Soc Trop Med Hyg 85:608–611

    CAS  PubMed  Google Scholar 

  • Brown MS, Kovanen DT, Goldstein JL (1980) Evolution of the LDL receptor concept from cultured cells to intact animals. Ann N Y Acad Sci 348:48–67

    CAS  PubMed  Google Scholar 

  • Burri C, Keiser J (2001) Pharmacokinetic investigations in patients from Northern Angola refractory to melarsoprol treatment. Trop Med Int Health 6:412–420

    Article  CAS  PubMed  Google Scholar 

  • Burri C, Baltz T, Girond C, Doua F, Welker HA, Brun R (1993) Pharmacokinetic properties of the trypanocidal drug Melarsoprol. Chemotherapy 39:225–234

    CAS  PubMed  Google Scholar 

  • Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun T (2000) Efficacy of a new, concise schedule for melarsoprol in treatment of sleeping sickness caused by T. b. gambiense: a randomised trial. Lancet 355:1419–1425

    Article  CAS  PubMed  Google Scholar 

  • Cater NS, Fairlamb AH (1993) Arsenical resistant trypanosome lack the unusual adenosine transporter. Nature 361:173–175

    Google Scholar 

  • Cater NS, Berger BJ, Fairlamb AH (1995) Uptake of diaimine drugs by the P2 nucleoside transporter in melarsen sensitive and resistant T. b. brucei. J Biol Chemistry 270:28153–28157

    Article  Google Scholar 

  • Collins JM, Klecker RW, Yarchoan R, Lane HC, Fauci AS, Redfield RR, Broder S, Meyers CE (1986) Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. J Clin Pharmacol 26:22–26

    CAS  PubMed  Google Scholar 

  • Damper D, Patton CL (1976) Pentamidine transport and sensitivity in brucei group trypanosomes. J Protozool 23:349–356

    CAS  PubMed  Google Scholar 

  • De Clercq E(1979) Suramin: a potent inhibitor of reverse transcriptase of RNA tumor viruses. Cancer Lett 8:9–22

    PubMed  Google Scholar 

  • De Koning HD (2001) Transporters in African trypanosomes: role in drug action and resistance. Int J Parasitol 31:512–522

    PubMed  Google Scholar 

  • De Koning HP, Jarvis SM (1999) Purine transporters in blood stream forms of T. brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol Pharmacol 56:1162–1170.

    PubMed  Google Scholar 

  • Dixon H, Ginger CD, Williamson J (1971) The lipid metabolism of blood and culture forms of T. lewisi and T. rhodesiense. Comp Biochem Physiol 39B:247–266

    Google Scholar 

  • Doua F, Miezan TW, Sanan Singaro JR, Boa YF, Baltz T (1996) The efficacy of pentamidine in the treatment of early stage T. b. gambiense trypanosomiasis. Am J Trop Med.Hyg 55:586–588

    CAS  Google Scholar 

  • Ericsson O, Schweda E, Bronner V, Rombo L, Frieden M, Gustafsson LL (1997) Determination of melarsoprol in biological fluids by high performance liquid chromatography and characterization of stereoisomers by nuclear magnetic resonance spectroscopy. J Chromatogr B Biomed Sci App 690:243–251

    Article  CAS  Google Scholar 

  • Feuillan P, Raffeld M, Stein CA, Lipford N, Rehaquist D, Meyers CE, LaRocca RV, Chrousos GP (1987) Effects of suramin on function and structure of adrenal cortex in cynomolgus monkey. J Clin Endocrinol Metab 65:153–158

    CAS  PubMed  Google Scholar 

  • Friedheim EAH (1949) MelB in the treatment of human trypanosomiasis. Am J Trop Med Hyg 29:173–180

    Google Scholar 

  • Goldstein JL, Anderson RGW, Brown MSL (1979) Coated pits, coated vesicles and receptor mediated endocytosis. Nature 279:679–685

    CAS  PubMed  Google Scholar 

  • Gutteridge WE (1969) Some effects of pentamidine diisothionate on Crithridia fasiculata. J Protozool 16:306–311

    CAS  PubMed  Google Scholar 

  • Harder A, Greif G, Haberkorn A (2001) Chemotherapeutic approaches to protozoa: Kinetoplastida—current knowledge and outlook. Parasitol Res 87:778–80

    Google Scholar 

  • Hawking F (1940) Concentration of Bayer 205 (Germanin) in human blood and cerebrospinal fluid after treatment. Trans R Soc Trop Med Hyg 34:37–52

    CAS  Google Scholar 

  • Hawking F (1978) Suramin with special reference to onchocerciasis. Adv Pharmacol Chemother 15:289–322

    CAS  PubMed  Google Scholar 

  • Hunter CA, Jennings FW, Adams JH, Murray M,Kenedy PGE (1992) Subcurative chemotherapy and fatal post-trearment reactive encephalopathies in African trypanosomes. Lancet 339:956–958

    CAS  PubMed  Google Scholar 

  • Kaminsky R, Mäser P (2000) Drug resistance in African trypanosomes. Curr Opin Anti-infect Invest Drugs 2:76–82

    CAS  Google Scholar 

  • Keiser J, Ericsson O, Burri C (2000) Investigations of the metabolites of the trypanocidal drug Melarsoprol. Clin Pharmacol Ther 67:478–488

    CAS  PubMed  Google Scholar 

  • Kimura H, Meguro T, Badr A, Zhang JH (2002) Suramin induced reversal of chronic cerebral vacospasm in experimental subarachroid hemmorhage. J Neurosurg 97:129–135

    CAS  PubMed  Google Scholar 

  • Kuzoe FAS (1993) Current situation of African trypanosomiasis. Acta Trop 54:153–162

    CAS  Google Scholar 

  • Legros D, Evans S, Maiso F, Enyaru JCK, Mbulamberi D (1999) Risk factors for the treatment failures after melarsoprol for T. b. gambiense trypanosomiasis in Uganda. Trans R Soc Trop Med Hyg 93:439–442

    CAS  PubMed  Google Scholar 

  • Maes L, Vandeveken M, Hamers R, Doua F, Cattand P (1988) The monitoring of trypanocidal treatment with a sensitive ELISA method measuring melarsoprol levels in serum and CSF. Ann Soc Belg Med Trop 68:219–231

    CAS  PubMed  Google Scholar 

  • Mahley RW, Innerarity TL, Pitas RE, Weisgraber KH, Brown JH, Gross E (1977) Inhibition of the lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in B apo proteins. J Biol Chem 252:7279–7287

    CAS  PubMed  Google Scholar 

  • Matovu E, Geiser F, Schneider V, Mäser P, Enyaru JC, Kamisnsky R, Gallati S, Seebeck T (2001a) Structural formula of suramin. Mol Biochem Parasitol 117:73–81

    Article  CAS  PubMed  Google Scholar 

  • Matovu E, Enyaru JCK, Schmid C, Seebeck T,Kaminsky R (2001b) Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health 6:497–411

    Article  Google Scholar 

  • Mbati PA, Hirumi K, Inoue N,Situakibanza NH, Hirumi H (2000) Suggested dosage rates of melarsoprol in the treatment of mice experimentally infected with T. b. gambiense. Onderstepoort J Vet Res 6:71–74

    Google Scholar 

  • Misset O, Opperdoes FR (1987) The phosphoglycerate kinases from T. brucei, a comparison of the glycosomal and cytosolic isozyme and their selectivity towards suramin. Eur J Biochem 162:493–500

    CAS  PubMed  Google Scholar 

  • Misset O, Bos OJM, Opperdoes FR (1986) Glycolytic enzymes of Trypanosoma brucei simultaneous purification, intraglycosomal concentration and physical properties. Eur J Biochem 157:441–453

    CAS  PubMed  Google Scholar 

  • Nun CM, Neide S (1995) Sequence dependent drug binding to the minor groove of DNA crystal structure of DNA dodecamer d(cgcaaatttgcg)2 complexed with propamidine. J Med Chem 38:2317–2325

    PubMed  Google Scholar 

  • Onyango RJ, Ogada T, Mwabi D (1968) The use of MelB in the treatment of T. b. rhodesiense sleeping sickness. EATRO Rep 82:3

    Google Scholar 

  • Opperdoes FR, Coppens I, Baudhuin P (1987) Digestive enzymes receptor mediated endocytosis and their role in the nutrition of blood stream trypanosomes. In: Chang K-P, Snary D (eds) Host parasite cellular and molecular interaction in protozoal infection.) Springer, Berlin Heidelberg New York, pp 51–66

  • Park BK, Kitterungham NR (1996) Drug protein conjugation and its immunological consequences. Drug Metab Rev 22:87–144

    Google Scholar 

  • Pepin J, Milord F (1994) The treatment of human African trypanosomiasis. Adv Parasitol 33:1–47

    PubMed  Google Scholar 

  • Sands M, Kron MA, Brown RB (1985) Pentamidine, a review. Rev Infect Dis 7:625–634

    CAS  PubMed  Google Scholar 

  • Schneider WJ, Beisiegel U, Goldstein JL, Brown MS (1982) Purification of low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem 257:2664–2673

    CAS  PubMed  Google Scholar 

  • Scott AG, Tait A, Turner CMR (1996a) T. brucei lack of cross resistance to melarsoprol in vitro by Cymelarsen-resistant parasites. Exp Parasitol 86:181–90

    Article  Google Scholar 

  • Scott AG, Tait A, Turner CMR (1996b) Characterization of cloned lines of T. brucei expressing stable resistance to MelCy and suramin. Acta Trop 60:251–262

    Article  CAS  PubMed  Google Scholar 

  • Shahi SK, Krauth-Siegel RL, Clayton CE (2002) Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance. Mol Microbiol 43:1129–1138

    Article  CAS  PubMed  Google Scholar 

  • Shapiro TA (1993) Inhibition of topoisomerases in African trypanosomes. Acta Trop 54:251–260

    CAS  PubMed  Google Scholar 

  • Soignet SL, Tong WP, Hirschfeld S, Warrell RPJr (1999) Clinical study of an organic arsenical, melarsoprol in patients with advanced leukemias. Cancer Chemother Pharmacol 44:417–421

    Article  CAS  PubMed  Google Scholar 

  • Vansterkenurg ELM, Coppens I, Wilting J, Bos OJM, Fischer MJE, Janssen LHM, Opperdoes FR (1993). The uptake of trypanocidal drug suramin in combination with LDL by T. brucei and its possible mode of action. Acta Trop 54:237–250

    CAS  PubMed  Google Scholar 

  • Voogd TE, Vansterkenurg ELM, Wilting J, Jansen LHM (1993) Recent research on biological activity of suramin. Pharmacol Rev 45:177–203

    CAS  PubMed  Google Scholar 

  • Waalker TP, Devita VT (1970) The determination of pentamidine (4,4-diaamidinophenoxypentane) in plasma, urine and tissues. J Lab Clin Med 75:871–878

    PubMed  Google Scholar 

  • Wierenge RK, Swinleels B, Mitchels PAM, Osinga K, Misste O, VanBeenmen J, Gibson WC, Postua JPM, Borst P, Opperdoes FR, Wol WGS (1987). Common elements in the surface of glycolytic enzymes from T. brucei may serve as topogenic signals for import glycosomes. EMBO J 6:215–221

    PubMed  Google Scholar 

  • Williamson M, Calleus M, Kunzt D, Perie J, Opperdoes FR (1993). Synthesis and activity of inhibitors highly specific for glycolytic enzymes from T. brucei: Mol Biochem Parasitol 59:201–210

    PubMed  Google Scholar 

  • Wood DH, Hall JE, Rose BG, Tidwell RR (1998) 1,5-Bis(4-amidinophenoxypentane) pentamidine is a potent inhibitor of H3-diazoxan binding to imidazole I2 binding sites. Eur J Pharmacol 353:97–103

    Article  CAS  PubMed  Google Scholar 

  • Zhang ZQ, Baltz T (1991) In vivo and in vitro sensitivity of T. evansi and T. equiperdum to diamine, suramin, MelCy, quinapyramine and isometamidium. Acta Trop 50:101–110

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria

    Andrew Jonathan Nok

Authors
  1. Andrew Jonathan Nok
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew Jonathan Nok.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nok, A.J. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res 90, 71–79 (2003). https://doi.org/10.1007/s00436-002-0799-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-002-0799-9

Keywords

Search

Navigation